Skip to main content
Equibles

TCXB · TCGX Acquisition Corp. II

Track TCXB — free

Use TCXB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TCXB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.17 At close · Nov 12
Rebalance outlook locked
Market Cap
$132.74M
Shares
12.95M
Volume · Nov 10 6422 Avg daily vol (17 sessions) 68.06K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.25 Open$10.25 Day$10.25–10.25 Available close range$10.10–10.86 Avg vol available · 17d68K Short int1K · 0.0% of shares · 1.0d Short vol50% DataOct 2026–Nov 2026

The closing range uses available history since Oct 16, 2026; less than a full year is stored.

Latest documents

2026
Sep 25
Registration statement S-1
Registration statement

TCGX Acquisition Corp. II plans an initial public offering of 10,000,000 Class A ordinary shares for $100,000,000 at $10.00 per share, without warrants, targeting healthcare and healthcare-related industries with no business combination target selected.

Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Neutral Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Neutral
50 / 200-day cross No cross
RSI (14) 29
oversold
52-week position 20%
mid-range
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 25
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 21%
annualized · 1-yr
Max drawdown −7%
past year
ATR 2.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
0 · 3 · 0
50 / 200-day cross
No cross Neutral
RSI (14)
29 Neutral
52-week position
20% Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of shares out · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $10 Now $10 · 20% Range high $11

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TCXB
TCGX Acquisition Corp. II
this stock
$132.74M — — — 0.0%
VYLR
Vylor Inc.
 $48.09B — — — 2.1%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
 $652.61M +3.5% — — 0.0%
EVAC
EQV Ventures Acquisition Corp. II
 $606.10M +3.4% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
1.5K
Days to cover
1.0d
Change
+1.5K sh
View
Short Volume
Short vol %
50%
As of
Nov 12, 2026
Short Total
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 19, 2026
This year
2

TCGX Acquisition Corp. II closed its IPO on October 19, 2026, selling 10,000,000 Class A ordinary shares at $10.00 per share for $100,000,000 gross proceeds, and placed $100,000,000 in a Citibank, N.A. trust account.

View
Earnings & Events
Investor Relations
Latest news
TCGX Acquisition Corp. II Announc…
Published
Oct 19, 2026
View

Performance

5D 20D 120D MTD YTD
TCXB +1.5% — — +1.1% —
SPY -0.6% -3.6% +1.2% -0.8% +10.0%
vs SPY +2.1% — — +1.9% —
Key facts CIK 2149916